\BOOKMARK [1][-]{section.1}{Literature review}{}% 1
\BOOKMARK [2][-]{subsection.1.1}{Penalised Non-Negative Matrix Tri-Factorisation}{section.1}% 2
\BOOKMARK [2][-]{subsection.1.2}{Drug sensitivity prediction}{section.1}% 3
\BOOKMARK [2][-]{subsection.1.3}{Drug sensitivity prediction}{section.1}% 4
\BOOKMARK [2][-]{subsection.1.4}{Performance}{section.1}% 5
\BOOKMARK [1][-]{section.2}{Penalised Non-Negative Matrix Tri-Factorisation}{}% 6
\BOOKMARK [2][-]{subsection.2.1}{Non-Negative Matrix Tri-Factorisation}{section.2}% 7
\BOOKMARK [2][-]{subsection.2.2}{Adding penalisation}{section.2}% 8
\BOOKMARK [2][-]{subsection.2.3}{Multiple penalisation matrices}{section.2}% 9
\BOOKMARK [2][-]{subsection.2.4}{Dealing with missing values}{section.2}% 10
\BOOKMARK [1][-]{section.3}{PNMTF for Missing Value Prediction}{}% 11
\BOOKMARK [1][-]{section.4}{Datasets}{}% 12
\BOOKMARK [1][-]{section.5}{PNMTF for Drug Sensitivity Prediction}{}% 13
\BOOKMARK [2][-]{subsection.5.1}{Constructing similarity matrices for penalisation}{section.5}% 14
\BOOKMARK [2][-]{subsection.5.2}{Prediction}{section.5}% 15
\BOOKMARK [2][-]{subsection.5.3}{Biological interpretation}{section.5}% 16
\BOOKMARK [1][-]{section.6}{Probabilistic PNMTF}{}% 17
\BOOKMARK [1][-]{section.7}{Multi-type PNMTF}{}% 18
\BOOKMARK [1][-]{section.8}{Project outline}{}% 19
